Skip to content

Dogwood Therapeutics, Inc.

DWTX· NasdaqCore metricsCIK 1818844

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -9.09%
Market cap
$42.05M
38.23M shares
Filings
332
$100.00K
Q3 2026
—
-$4.88M
Q3 2026N/M FY25 yoy
-$4.92M
Q3 2026N/M FY25 yoy
—
—
—
-$0.14
Q3 2026N/M FY25 yoy
$4.95M
Q3 2026−56.1% FY25 yoy
$42.05M
—
—
0.7×
—
—

FY2025 figures · derived

Price

$1.1080.50%$4.54past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$100.00KQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Dogwood Therapeutics, Inc. is the 341st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Dogwood Therapeutics, Inc. · CIK 1818844 · Engraved from SEC EDGAR